Pedrinelli R, Sassano P, Arzilli F, Magagna A, Salvetti A
J Cardiovasc Pharmacol. 1981 Nov-Dec;3(6):1153-61. doi: 10.1097/00005344-198111000-00001.
We studied the role of alpha-adrenoceptors in controlling renin release by infusing increasing doses of phentolamine into six patients with essential hypertension. Furthermore, in order to evaluate the relative importance of alpha 1- and alpha 2-adrenoceptors, phentolamine infusion was repeated in the same patients after pretreatment with prazosin, a selective alpha 1-blocking agent, and oxprenolol, a nonselective beta-blocker. After placebo, phentolamine infusion did not change mean blood pressure or heart rate and increased plasma renin activity (PRA) in a dose-dependent fashion. This finding suggests that the drug acts directly on the intrarenal renin producing apparatus and seems to confirm the inhibitory role of alpha-adrenoceptors in the control of renin release. After prazosin and oxprenolol pretreatment, PRA was respectively increased and decreased but it was unmodified by phentolamine infusion. This latter finding may indicate that both alpha 1- and alpha 2-adrenoceptors are involved in renin release or that alpha-adrenoceptors cannot be clearly differentiated into alpha 1- and alpha 2-subtypes.
我们通过向6例原发性高血压患者输注递增剂量的酚妥拉明,研究了α-肾上腺素能受体在控制肾素释放中的作用。此外,为了评估α1和α2肾上腺素能受体的相对重要性,在同一患者中,先用选择性α1阻滞剂哌唑嗪和非选择性β阻滞剂氧烯洛尔预处理后,重复输注酚妥拉明。给予安慰剂后,输注酚妥拉明未改变平均血压或心率,并以剂量依赖方式增加血浆肾素活性(PRA)。这一发现表明,该药物直接作用于肾内肾素产生装置,似乎证实了α-肾上腺素能受体在控制肾素释放中的抑制作用。在哌唑嗪和氧烯洛尔预处理后,PRA分别升高和降低,但酚妥拉明输注对其无影响。后一发现可能表明,α1和α2肾上腺素能受体均参与肾素释放,或者α-肾上腺素能受体不能明确区分为α1和α2亚型。